Back
ESC2025 Premium Access

ROBO4 triggers pulmonary arterial hypertension through promoting the progressive reduction of pulmonary micro-vessels and the remodeling of distal pulmonary arterioles

Session: Pathobiology of pulmonary hypertension
Topic: Pathophysiology and Mechanisms
Speaker: Doctor X. Zou (Hangzhou, CN)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Xiaozhou Zou

Zhejiang People's Hospital, Hangzhou (China)
0 follower

4 more presentations in this session

The interaction of bone morphogenetic protein receptor type 2 and pentraxin 3 on inflammation and fibrosis: implications for pulmonary hypertension

Speaker: Professor P. Liu (Tainan, TW)

Access
Abstract
Slides
Video
Like
Thumbnail

Targeting alpha 5 beta 1 integrin as a therapeutic strategy to combat right ventricular dysfunction in pulmonary arterial hypertension

Speaker: Miss S. Lemay (Quebec, CA)

Access
Abstract
Slides
Video
Like
Thumbnail

Spatial proteomics unveils region-specific alterations in right ventricular remodeling rats under pressure overload

Speaker: Ms J. Zhang (Beijing, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

Comparative analysis of microRNA expression in idiopathic pulmonary arterial hypertension and Eisenmenger syndrome: Insights into vascular remodeling and disease progression

Speaker: Doctor D. Miskowiec (Lodz, PL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Pathobiology of pulmonary hypertension

Speakers: Doctor X. Zou, Professor P. Liu, Miss S. Lemay, Ms J. Zhang, Doctor D. Miskowiec
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources